Dr. Lisamarie LoGiudice's intellectual property practice is focused on pharmaceutical and biotechnology patent litigation in district court and post-grant invalidity proceedings before the United States Patent and Trademark Office's (USPTO) Patent Trial and Appeal Board (PTAB). Her litigation experience spans pre-lawsuit investigation all the way through appeals to the Federal Circuit. She also has experience providing patent prosecution strategy advice, due diligence evaluations of patent portfolios, analyzing the validity of patents, and freedom-to-operate analyses.
Prior to joining Jones Day, Lisamarie received a doctorate in neuroscience from Stony Brook University where her research focused on the mechanisms and molecular underpinnings of synaptic transmission. During her time at Stony Brook, she coauthored several peer-reviewed publications in the fields of molecular and cellular neurobiology.
Despite Granting a Request for Rehearing, the PTAB Maintained Its Finding that Teva’s Copaxone Claims Were Unpatentable as Obvious, PTAB Litigation Blog
Invalidity Defenses Raised but not Instituted During IPR Are not Barred by Statutory or Judicial Estoppel, PTAB Litigation Blog
- Brooklyn Law School (J.D. cum laude 2012); Stony Brook University (Ph.D. in Neuroscience 2009; B.S. in Biology 2002)
- New York, U.S. Court of Appeals for the Federal Circuit, U.S. District Courts for the Southern and Eastern Districts of New York, and registered to practice before the U.S. Patent and Trademark Office